Noidecs Launches New THCV-Rich Product for UK Medical Patients
Noidecs has introduced the UK's first commercially available THCV-rich medical cannabis product, targeting patients with metabolic conditions, appetite dysregulation, and treatment-resistant anxiety.
Noidecs, an Australian pharmaceutical cannabis company with a growing UK presence, has launched what it describes as the first commercially available THCV-rich medical cannabis product accessible through standard UK clinical prescribing channels. The product is aimed at a specific patient population where the unique pharmacological properties of tetrahydrocannabivarin offer potential therapeutic advantages.
What Is THCV
THCV is a cannabinoid structurally similar to THC but with distinct pharmacological properties. Unlike THC, THCV is typically associated with appetite suppression rather than stimulation, a more energising and mentally clear effect profile, and potential benefits in metabolic regulation. It has attracted growing scientific interest for applications in obesity, type 2 diabetes management, anxiety, and certain tremor-related neurological conditions.
- THCV is an antagonist at CB1 receptors at lower doses, unlike THC which is an agonist
- Associated with appetite suppression, potentially useful for metabolic conditions
- May produce a clearer, more focused effect than THC-dominant products
- Emerging evidence supports use in anxiety, particularly where THC sensitivity is a concern
The Noidecs Product
The new product is a standardised dry flower cultivar with elevated THCV content alongside moderate CBD, intended for vaporisation using an approved medical device. It will be available through the UK distribution network and can be prescribed by specialist clinicians with access to the Noidecs formulary. This represents the first time UK patients can access a purpose-developed THCV-dominant preparation through standard prescribing channels.
Patients being treated for conditions where appetite management, metabolic support, or a less sedating cannabinoid effect profile is desirable may be candidates for THCV-containing products. Discuss availability and suitability with your prescribing specialist. Explore further options in our strain directory or find a suitable clinic through our clinic finder. Our prescription guide helps new patients navigate the system.
